Solvac (SOLV) H1 2025 earnings summary

Executive summary

• Cash income for H1 2025 remained stable at €132.1 million, driven by dividends from Solvay and Syensqo, matching H1 2024 levels.

• Net profit for H1 2025 increased by €21.2 million year-over-year to €97.2 million, mainly due to a higher final dividend from Solvay.

• The company’s assets consist exclusively of significant stakes in Solvay SA and Syensqo SA, with a market capitalization of €1.9 billion as of June 30, 2025.

Financial highlights

• Cash result for H1 2025 was €128.7 million, after operational and financial charges.

• Financial income rose to €100.5 million in H1 2025 from €79.3 million in H1 2024, reflecting increased dividends.

• Operating expenses increased by 7% year-over-year, mainly due to higher AGM and board meeting costs.

• Net financial charges decreased by €112k, as lower short-term debt costs offset higher long-term interest rates.

• Net profit per share for H1 2025 was €4.55, up from €3.55 in H1 2024.

Outlook and guidance

• The first interim dividend for 2025 is set at €2.905 gross per share, representing 50% of the previous year’s total dividend.

• The net interim dividend is €2.03 per share, payable on September 25, 2025.

• The final dividend for 2025 will be determined and announced after the May 2026 AGM.